Drug Profile
Measles and rubella virus vaccine - Mitsubishi Tanabe
Alternative Names: MearubikLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator BIKEN
- Developer Mitsubishi Tanabe Pharma Corporation
- Class Measles vaccines; Rubella vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Measles; Rubella
Most Recent Events
- 01 Dec 2005 Launched for Measles in Japan (IM)
- 01 Dec 2005 Launched for Rubella in Japan (IM)